Pricing Log in Create free account
Saturday 17 October 2026 Export STE’s income statement to Excel — free account

STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

STERIS plc (STE) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, STERIS plc (STE) trades at a EV/EBITDA of 14.2×. Over the past ten years it has ranged from 13.1× (August 2015) to 33.5× (August 2021); the current reading is higher than 9% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2026 14.6× (18.99%)
FY2025 18.0× 2.11%
FY2024 17.7× 8.79%
FY2023 16.2× (32.29%)
FY2022 24.0× 4.10%
FY2021 23.0× 33.01%
FY2020 17.3× (6.04%)
FY2019 18.4× 20.38%
FY2018 15.3× 1.48%
FY2017 15.1× (15.14%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 13.5× (7.93%)
Mar 2026 14.6× (18.02%)
Dec 2025 17.8× 0.06%
Sep 2025 17.8× (1.06%)
42 more quarters

Against its own ten years

Low 13.1× High 33.5×
Ten-year median 17.8×
Current reading's percentile 9

EV/EBITDA against peers

Company EV/EBITDA
SNN Smith & Nephew SNATS, Inc. compare 6.0×
PHG Koninklijke Philips N.V. compare 8.8×
ZBH Zimmer Biomet Holdings, Inc. compare 11.0×
GMED Globus Medical, Inc. compare 11.4×
GEHC GE HealthCare Technologies Inc. compare 12.3×
STE STERIS plc 14.2×
DXCM DexCom, Inc. compare 23.5×
PEN Penumbra, Inc. compare 58.6×
BIO.B Bio-Rad Laboratories, Inc. compare 176×
Medical Devices industry median 11.5×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on STE